IDEAYA Biosciences
IDYA
29 hedge funds and large institutions have $83.6M invested in IDEAYA Biosciences in 2019 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 3 increasing their positions, 6 reducing their positions, and 7 closing their positions.
71% more first-time investments, than exits
New positions opened: 12 | Existing positions closed: 7
69% more capital invested
Capital invested by funds: $49.5M → $83.6M (+$34.2M)
27.41% more ownership
Funds ownership: 27.44% → 54.85% (+27%)
21% more funds holding
Funds holding: 24 → 29 (+5)
50% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 6
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$250K |
| 2 |
OGC
One68 Global Capital
New York
|
+$199K |
| 3 |
6CM
683 Capital Management
New York
|
+$160K |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$144K |
| 5 |
AIM
Alambic Investment Management
Belvedere,
California
|
+$141K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DM
Deerfield Management
New York
|
-$3.81M |
| 2 |
Victory Capital Management
San Antonio,
Texas
|
-$1.32M |
| 3 |
Goldman Sachs
New York
|
-$306K |
| 4 |
Millennium Management
New York
|
-$167K |
| 5 |
LCM
Laurion Capital Management
New York
|
-$156K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
TRCT
26
Tower Research Capital (TRC)
New York
| $3K | -$9.02K | -1,265 | -74% |
|
|
PHK
27
Point72 Hong Kong
Hong Kong
| $1K | – | – | – |
|
|
PAM
28
Panagora Asset Management
Boston,
Massachusetts
| $1K | +$1.14K | +160 | New |
|
29
Citigroup
New York
| $1K | +$1.21K | +170 | New |
|
|
DM
30
Deerfield Management
New York
| – | -$3.81M | -422,974 | Closed |
|
|
31
Victory Capital Management
San Antonio,
Texas
| – | -$1.32M | -146,780 | Closed |
|
|
LCM
32
Laurion Capital Management
New York
| – | -$156K | -17,300 | Closed |
|
|
BCM
33
BlueCrest Capital Management
St Helier,
Jersey
| – | -$135K | -15,000 | Closed |
|
34
HSBC Holdings
London,
United Kingdom
| – | -$93K | -10,316 | Closed |
|
35
UBS Group
Zurich,
Switzerland
| – | -$27K | -3,023 | Closed |
|
36
US Bancorp
Minneapolis,
Minnesota
| – | -$5K | -500 | Closed |
|
IDYA Hedge Fund Activity: Q4 2019 in Review
29 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in IDEAYA Biosciences (IDYA) for Q4 2019, worth a combined $83.6M — up 69% from $49.5M a quarter earlier.
Buyers outnumbered sellers: 12 funds opened new IDYA positions and 7 closed out — a net gain of 5 holders — while 3 added to existing stakes and 6 trimmed.
The largest buyer was Bridgeway Capital Management, adding an estimated $250K. The largest seller was Deerfield Management, exiting entirely with an estimated $3.81M sold.
- 29 institutional investors held IDEAYA Biosciences (IDYA) as of Q4 2019, up from 24 in Q3 2019.
- Funds reported $83.6M of IDEAYA Biosciences stock for Q4 2019, up 69% quarter-over-quarter.
- 12 funds opened new IDEAYA Biosciences positions in Q4 2019 and 7 closed out, a net change of +5 holders.
- The largest IDEAYA Biosciences buyer in Q4 2019 was Bridgeway Capital Management, an estimated $250K added.
- The largest IDEAYA Biosciences seller in Q4 2019 was Deerfield Management, an estimated $3.81M sold.
Based on aggregated 13F filings for Q4 2019.